The Aristocrat Group has been carefully planning two major product launches. Targeting a summer release for both, the company is preparing for major growth in the second half of 2013.

GlobalWise Investments and its wholly owned subsidiary Intellinetics, a leading-edge technology company focused on the design, implementation, and management of cloud-based Enterprise Content Management (“ECM”) systems in both the public and private sectors, today reported the signing of a new channel sales partnership with Toshiba Business Solutions AZ/CO (www.tbs.toshiba.com).

GNCC Capital holds six different gold and silver exploration properties in Arizona that the company plans to develop through the use of exploration, testing, and joint ventures.

Current gold properties:

• Burnt Well Gold Properties
• Ester Basin Gold Properties
• Clara Gold Properties

Current silver properties:

• Kit Carson Silver Properties
• Potts Mountain Silver Properties
• Silverfields Silver Properties

Rafarma Pharmaceuticals is one of Russia’s newest and most promising pharmaceutical companies. A company whose development and growth is being actively encouraged by the government, in a move to lessen Russian dependence upon western pharmaceutical companies for widely used pharmaceuticals, Rafarma is currently specializing in the production of generic antibiotics, but has a growing pipeline of other drugs, including proprietary products already approved.

As the $6 billion U.S. market for gluten-free products continues to expand, the Aristocrat Group Corp. announced today that it is working closely with Distilled Resources, Inc. (DRInc) to ensure that its debut vodka brand meets all the necessary requirements to be certified “gluten-free” by the federal government.

International Stem Cell, a biotech company developing novel stem cell-based therapies, today reported its financial results for the first quarter ended March 31, 2013.

Quarterly revenues increased 19 percent to $1.29 million from $1.08 million reported in the first quarter of the year prior. Revenues for Lifeline Skin Care (LSC) increased by 19 percent while revenue for Lifeline Cell Technology (LCT) increased by 20 percent, accounting for 51 percent and 49 percent of total quarterly revenue, respectively.